Imprint
ABX-CRO
advanced pharmaceutical services
Forschungsgesellschaft mbH
Schössergasse 19
01067 Dresden · Germany
Telephone: +49 . 351 . 21444-0
Telefax: +49 . 351 . 21444 -15
Dr. Andreas Kluge
General Manager
e-mail: info[at]abx-cro.com
Amtsgericht Dresden HRB21253
USt-ID DE 813 528 365
CONTACT
For any queries regarding licensing and pricing please contact the sales representative in your area. Further training and support is provided by ABX-CRO.
Support & Development
ABX-CRO advanced pharmaceutical
services Forschungsgesellschaft mbH
Schössergasse 19
01067 Dresden, Germany
Phone +49 (0) 351 21444-212
Telefax +49 (0) 351 214 44-15
qdose[at]abx-cro.com
www.abx-cro.com
Sales Europe
qdose[at]abx-cro.com
Phone +49 (0) 351 21444-0
ABX-CRO’s quality management is certified according to ISO 9001:2015 as well as ISO 13485:2016. QDOSE® conforms to the European Medical Regulation (Regulation EU 2017/745) and is CE-marked as
Medical Device (Class IIa) for clinical use inside the European Union.
Outside the EU, QDOSE® can be used for research purposes only.
Medical Device (Class IIa) for clinical use inside the European Union.
Outside the EU, QDOSE® can be used for research purposes only.